LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse

Novel progesterone receptor modulators with gene selective and context-dependent partial agonism

(2008) Thomas J. Berrodin et al.   BIOCHEMICAL PHARMACOLOGY

Liver X Receptors (LXR) as Therapeutic Targets in Dyslipidemia

(2008) Jerzy Bełtowski   Cardiovascular Therapeutics

Recent Advances in Liver X Receptor Biology and Chemistry

(2008) Bryan Goodwin et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE*3Leiden mice: time course and mechanisms

(2008) Lars Verschuren et al.   JOURNAL OF LIPID RESEARCH

Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia

(2008) Adelheid Kratzer et al.   JOURNAL OF LIPID RESEARCH

Indazole-Based Liver X Receptor (LXR) Modulators with Maintained Atherosclerotic Lesion Reduction Activity but Diminished Stimulation of Hepatic Triglyceride Synthesis∥

(2008) Jay Wrobel et al.   JOURNAL OF MEDICINAL CHEMISTRY

Antiatherosclerotic Effects of a Novel Synthetic Tissue-Selective Steroidal Liver X Receptor Agonist in Low-Density Lipoprotein Receptor-Deficient Mice

(2008) D. Peng et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells

(2008) Elizabeth A DiBlasio-Smith et al.   Journal of Translational Medicine

Differential Biochemical and Cellular Actions of Premarin Estrogens: Distinct Pharmacology of Bazedoxifene-Conjugated Estrogens Combination

(2008) Thomas J. Berrodin et al.   MOLECULAR ENDOCRINOLOGY

Carboxylic acid based quinolines as liver X receptor modulators that have LXRβ receptor binding selectivity

(2007) Baihua Hu et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS